Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment

NCT03752489 is registered in ClinicalTrials.gov with Dascena as lead sponsor.

NCT NCT03752489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03752489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment
Lead sponsor
Dascena
Phase
Phase 2
Overall status
Unknown status
Start date
April 1, 2022
Completion date
March 31, 2024
Enrollment
51,645 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock, severe sepsis